Nitric Oxide Up-Regulates RUNX2 in LNCaP Prostate Tumours: Implications for Tumour Growth In Vitro and In Vivo (scientific article published on 19 July 2015)

Apoptosis signal-regulating kinase 1-mediated signaling pathway regulates nitric oxide-induced activator protein-1 activation in human bronchial epithelial cells

Q51683319

Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells

Q28237966

Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions

Q30435146

Normalization of the Vasculature for Treatment of Cancer and Other Diseases

Q30471456

Guidelines for the welfare and use of animals in cancer research

Q33903753

Nitric oxide: NO apoptosis or turning it ON?

Q34214972

Nitric oxide and mechanisms of redox signalling: matrix and matrix-metabolizing enzymes as prime nitric oxide targets

Q34430700

Runx2-Smad signaling impacts the progression of tumor-induced bone disease

Q34898865

Runx2 Protein Stabilizes Hypoxia-inducible Factor-1α through Competition with von Hippel-Lindau Protein (pVHL) and Stimulates Angiogenesis in Growth Plate Hypertrophic Chondrocytes

Q35922634

Targeting Runx2 expression in hypertrophic chondrocytes impairs endochondral ossification during early skeletal development

Q35985042

Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development

Q36117930

A role for Runx2 in normal mammary gland and breast cancer bone metastasis

Q36211777

Cytoprotective Signaling Associated with Nitric Oxide Upregulation in Tumor Cells Subjected to Photodynamic Therapy-like Oxidative Stress

Q36674615

Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells

Q37000350

Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer

Q37170747

Ectopic runx2 expression in mammary epithelial cells disrupts formation of normal acini structure: implications for breast cancer progression

Q37343805

Pro-survival and pro-growth effects of stress-induced nitric oxide in a prostate cancer photodynamic therapy model

Q37417193

The yin and yang of nitric oxide in cancer progression.

Q38077081

Nitric oxide-p38 MAPK signaling stabilizes mRNA through AU-rich element-dependent and -independent mechanisms

Q38294258

ARED 2.0: an update of AU-rich element mRNA database.

Q38430539

Parathyroid hormone-related protein protects renal tubuloepithelial cells from apoptosis by activating transcription factor Runx2.

Q39201922

Increased expression of activated endothelial nitric oxide synthase contributes to antiandrogen resistance in prostate cancer cells by suppressing androgen receptor transactivation.

Q39275054

Androgen deprivation results in time-dependent hypoxia in LNCaP prostate tumours: informed scheduling of the bioreductive drug AQ4N improves treatment response.

Q39292683

Runx2-mediated bcl-2 gene expression contributes to nitric oxide protection against hydrogen peroxide-induced osteoblast apoptosis

Q39800854

Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin

Q39897646

Hypoxia selects for androgen independent LNCaP cells with a more malignant geno- and phenotype

Q39977133

Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling

Q40150534

Nitric oxide-mediated inhibition of androgen receptor activity: possible implications for prostate cancer progression

Q40230325

Nitric oxide attenuates resistance to doxorubicin in three-dimensional aggregates of human breast carcinoma cells

Q40343161

Dexamethasone inhibits insulin-induced chondrogenesis of ATDC5 cells by preventing PI3K-Akt signaling and DNA binding of Runx2.

Q40515610

Nitric oxide increases IL-8 gene transcription and mRNA stability to enhance IL-8 gene expression in lung epithelial cells

Q40550831

Bicalutamide-induced hypoxia potentiates RUNX2-mediated Bcl-2 expression resulting in apoptosis resistance

Q41314252

Osteogenic differentiation of human mesenchymal bone marrow cells in silk scaffolds is regulated by nitric oxide

Q41339493

CRE DNA binding proteins bind to the AP-1 target sequence and suppress AP-1 transcriptional activity in mouse keratinocytes

Q42470001

Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2.

Q44058493

P433

issue

P304

page(s)

473-482

P577

publication date

2015-07-19

P1433

published in

Journal of Cellular Physiology

Q1524270

P1476

title

Nitric Oxide Up-Regulates RUNX2 in LNCaP Prostate Tumours: Implications for Tumour Growth In Vitro and In Vivo

P478

volume

231

Reverse relations

cites work (P2860)

Q64118105	Differentially Expressed Genes and Molecular Pathways in an Autochthonous Mouse Prostate Cancer Model
Q38733024	Distinct Osteomimetic Response of Androgen-Dependent and Independent Human Prostate Cancer Cells to Mechanical Action of Fluid Flow: Prometastatic Implications.
Q38704618	Metabolic Modification in Gastrointestinal Cancer Stem Cells: Characteristics and Therapeutic Approaches
Q38829378	MiR-30a regulates the proliferation, migration, and invasion of human osteosarcoma by targeting Runx2.
Q47399023	Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors.
Q33850244	ZEB2 promotes tumor metastasis and correlates with poor prognosis of human colorectal cancer